AIDS

Pharmalot By Ed Silverman

AIDS groups criticize Express Scripts for excluding several HIV medicines

Pharmalot By Ed Silverman

Gilead’s HIV prevention pill can greatly reduce new infections in targeted rollouts

Pharmalot By Ed Silverman

AIDS activists urge N.Y. attorney general to probe Gilead for antitrust violations

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Another PBM refuses to pay for the EpiPen rival

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Glaxo touts a two-drug regimen for HIV

Health By Helen Branswell

Patient Zero in AIDS crisis was misidentified, study says, rewriting early history of virus

In the Lab By Sharon Begley

CRISPR identifies genes that might be targeted to hobble HIV infection

Heavyweights By Rebecca Robbins

The drug pricing crusader at the center of one of the nastiest fights of the election season